Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease

Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease

Background/AimsThe clinical use of measuring infliximab (IFX) trough levels (TLs) and antibodies against IFX (ATIs) in patients with pediatric inflammatory bowel disease (IBD) remains unclear. We propose measuring these variables to create individual IFX treatment strategies for patients with pediat...

Full description

Bibliographic Details
Main Authors: So Yoon Choi, Ben Kang, Jee Hyun Lee, Yon Ho Choe
Format: Article
Language:English
Published: Gastroenterology Council for Gut and Liver 2017-01-01
Series:Gut and Liver
Subjects:
pediatric inflammatory bowel disease
infliximab
trough level
antibodies
Online Access:http://gutnliver.org/journal/view.html?doi=10.5009/gnl16041

Internet

http://gutnliver.org/journal/view.html?doi=10.5009/gnl16041

Similar Items